May backs UK to be leader in AI in healthcareUK prime minister Theresa May backed artificial intelligence to diagnose several types of cancer in a speech on Monday, said that day’s FT. (APMHE 58170)
Takeda CEO says Shire acquisition will make company more resilient to pricing pressuresTakeda’s chief executive Christophe Weber said the acquisition of Shire will strengthen the company’s focus on innovative medicines and make it more “resilient” to pricing pressures in the U.S., the FT said on Monday.
Pfizer under pressure to resolve shortages of EpiPenMylan, the company behind the EpiPen allergy injector, is pressing its manufacturing partner Pfizer to do more to tackle shortages of the life-saving medicine in a sign of its growing frustration with the big pharma company, the FT reported on Thursday.
Pfizer agrees to pay nearly $24 million to settle kickback claimsPfizer has agreed to pay almost $24 million to settle claims it paid kickbacks to Medicare patients who used its medicines, the U.S. Department of Jusice said, the FT reported on Thursday.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.